AFP and metabolic dysfunction-associated steatotic liver disease: Patients with NAFLD were also less frequently diagnosed as part of a surveillance protocol (47.6 vs. 63.3%) and had significantly lower serum levels of alpha-fetoprotein (AFP) (median 7.13 vs. 20.4 ng/dL).